Revolade Eltrombopag 50 Mg Tablet

450 INR/Box

Get a Price/Quote

Product Details:

Dosage Form Tablet
Salt Composition Eltrombopag 50 mg
Indication Used for treatment of low blood platelet count in patients with chronic immune (idiopathic) thrombocytopenic purpura (ITP), hepatitis C-associated thrombocytopenia, and severe aplastic anemia.
Enzyme Types Not Applicable (non-enzymatic medicinal product)
Feature Boosts platelet production by stimulating thrombopoietin receptors
Ingredients Eltrombopag Olamine; excipients q.s.
Application Oral administration as directed by physician
Click to View more
Share Your Product:

Request to Call Back Send Inquiry

Revolade Eltrombopag 50 Mg Tablet Price And Quantity

Price 450 INR/Box

Packaging Type Blister pack
Pack Size 7 or 14 tablets per box
Brand Name Revolade
Control Status Not a controlled substance
Marketed By Novartis India Limited
Regulatory Approval US FDA, EMA, India CDSCO approved
Prescription Status Prescription-only (Rx)
Usage Precautions Monitor liver function; avoid use in patients with hepatic impairment unless directed
Contraindications Hypersensitivity to eltrombopag; hepatic failure; pregnancy and lactation (unless clearly needed)
Administration Route Oral
ATC Code B02BX05

Revolade Eltrombopag 50 Mg Tablet Product Specifications

Enzyme Types Not Applicable (non-enzymatic medicinal product)
Salt Composition Eltrombopag 50 mg
Physical Color/Texture Brown, round, film-coated tablet
Application Oral administration as directed by physician
Feature Boosts platelet production by stimulating thrombopoietin receptors
Dosage Form Tablet
Shelf Life 24 Months
Indication Used for treatment of low blood platelet count in patients with chronic immune (idiopathic) thrombocytopenic purpura (ITP), hepatitis C-associated thrombocytopenia, and severe aplastic anemia.
Ingredients Eltrombopag Olamine; excipients q.s.
Fermentation Smell Odorless
Storage Instructions Store below 30C; Protect from moisture and light

Packaging Type Blister pack
Pack Size 7 or 14 tablets per box
Brand Name Revolade
Control Status Not a controlled substance
Marketed By Novartis India Limited
Regulatory Approval US FDA, EMA, India CDSCO approved
Prescription Status Prescription-only (Rx)
Usage Precautions Monitor liver function; avoid use in patients with hepatic impairment unless directed
Contraindications Hypersensitivity to eltrombopag; hepatic failure; pregnancy and lactation (unless clearly needed)
Administration Route Oral
ATC Code B02BX05

Product Description

Product details

Country of Origin : Made in India
Packaging Size : 14 Tablet in one Box
Treatment : low platelet count due to ITP or HCV infection
Manufacturer : Glaxo SmithKline Pharmaceuticals Ltd
Composition : Eltrombopag 50mg
Brand : Revolade 50 mg

How Revolade Eltrombopag Works

Revolade Eltrombopag 50 mg stimulates thrombopoietin receptors in the bone marrow, encouraging your body to produce more platelets. This mechanism is especially beneficial for patients with low platelet counts stemming from chronic ITP, hepatitis C, or severe aplastic anemia where bleeding risks are higher due to insufficient platelets.

Proper Administration and Dosage

Always take Revolade as prescribed by your physician. Swallow the tablet whole with water, preferably at the same time each day. Dosage may vary based on your platelet count, medical history, or specific condition. It is crucial to avoid altering the dose or stopping treatment abruptly without consulting your healthcare provider.

Safety Precautions and Contraindications

Before using Revolade, inform your doctor about any liver issues or other significant health problems. The medication is contraindicated for patients with known hypersensitivity to eltrombopag, those with hepatic failure, pregnant or lactating women unless clearly necessary. Regular monitoring of liver function tests is recommended during therapy.

FAQ's of Revolade Eltrombopag 50 Mg Tablet:

Q: What conditions does Revolade Eltrombopag 50 mg Tablet treat?

A: Revolade is indicated for the treatment of low blood platelet counts in patients with chronic immune (idiopathic) thrombocytopenic purpura (ITP), hepatitis C-associated thrombocytopenia, and severe aplastic anemia when alternative treatments are insufficient.

Q: How should I take Revolade Eltrombopag tablets?

A: Take one tablet orally as directed by your physician, preferably at the same time each day. Swallow the tablet whole with water, without crushing, chewing, or splitting. Your doctor may adjust the dose based on your response and platelet levels.

Q: When will I start to see the effects of Revolade?

A: The improvement in platelet count typically appears within 1-2 weeks of starting Revolade, although the response can vary among individuals. Continued use and regular monitoring are essential for optimal benefit.

Q: Where should I store Revolade Eltrombopag tablets?

A: Store the tablets in their original blister packaging below 30C. Keep them away from moisture, heat, and direct sunlight. Always keep the medicine out of reach of children.

Q: What are the key usage precautions for Revolade?

A: Monitor liver function regularly and avoid taking Revolade if you have hepatic impairment unless specifically instructed by a physician. The tablet should not be used in individuals with hypersensitivity to eltrombopag, hepatic failure, or during pregnancy and lactation except under essential circumstances.

Q: How does Revolade Eltrombopag benefit patients with low platelet counts?

A: By stimulating thrombopoietin receptors, Revolade increases platelet production in the bone marrow, thereby reducing the risk of bleeding and related complications in conditions with chronically low platelet counts.

Tell us about your requirement

Price:

Quantity

Select Unit

50
100
200
250
500
1000+

Additional detail

Mobile number

Other Products in 'Anti Cancer Drugs And Injection' category

Stivarga Regorafenib 40 Mg Tablet Price : 75000 INR/Bottle Minimum Order Quantity : 1 Feature : Other, Multikinase inhibitor with antiangiogenic and antiproliferative effects Application : Other, Oral administration for oncology therapy Dosage Form : Tablet Physical Color/Texture : Other , Light brown, round, filmcoated tablets Salt Composition : Regorafenib 40 mg Storage Instructions : Store below 30C in a dry place, protect from light and moisture Shelf Life : 2436 months (refer to packaging) Indication : Treatment of metastatic colorectal cancer, gastrointestinal stromal tumors (GIST), and hepatocellular carcinoma (HCC) Ingredients : Other , Regorafenib; Excipients Enzyme Types : Other, Tyrosine Kinase Inhibitor (TKI) Fermentation Smell : Other, Odorless

Send Inquiry

ZYROP 10000 (Recombinant Human Erythropoietin Injection IU Feature : Other, Sterile, pyrogenfree, singleuse, readytoinject Application : Other, Increase red blood cell production; manage anemia Dosage Form : Injection Physical Color/Texture : Other , Clear, colorless to slightly yellow solution Salt Composition : Recombinant Human Erythropoietin Alfa 10000 IU Storage Instructions : Store in a refrigerator (2C to 8C). Do not freeze. Shelf Life : 24 months (from date of manufacture under proper storage conditions) Indication : Treatment of anemia especially in chronic kidney disease and cancer chemotherapy patients Ingredients : Other , Recombinant Human Erythropoietin, excipients (buffer, stabilizers, preservatives) Enzyme Types : Other, Nonenzymatic glycoprotein Fermentation Smell : Other, Odorless (as a finished injectable solution)

Send Inquiry

Nublast - Temozolamide 100 Mg Capsules Price : 40 INR/Piece Minimum Order Quantity : 100 Feature : Other Application : Other Dosage Form : Capsules Physical Color/Texture : White Powder Salt Composition : Temozolomide 100 mg Storage Instructions : Store below 25C in a dry place, protect from light Shelf Life : 24 months Indication : Treatment of certain types of brain tumors (anaplastic astrocytoma, glioblastoma multiforme) Ingredients : Other Enzyme Types : Enzyme Preparations

Send Inquiry

Dacilon Dactinomycin 0.5 Mg Injection Price : 300 INR/Piece Minimum Order Quantity : 1 Feature : Other, Cytotoxic, antibiotic antineoplastic agent Application : Other, Intravenous injection for oncology/chemotherapy Dosage Form : Injection Physical Color/Texture : Other , Lyophilized powder, orangered coloration Salt Composition : Dactinomycin (0.5mg) Storage Instructions : Store below 25C. Protect from light. Reconstituted solution should be used immediately or as per hospital protocol. Shelf Life : 24 Months Indication : Used in treatment of various cancers like Wilms tumor, rhabdomyosarcoma, Ewings sarcoma, and testicular cancer. Ingredients : Vitamin Fermentation Smell : Other, Odorless

Send Inquiry

SEND INQUIRY CALL ME FREE